Adverse event risk assessment of raloxifene in postmenopausal women with osteoporosis

被引：0
|
作者：
Chlebowski, RT [1 ]
Cauley, JA [1 ]
Disch, D [1 ]
Secrest, RJ [1 ]
Mershon, JL [1 ]
机构：
[1] Univ Calif Los Angeles, Res & Educ Inst, Torrance, CA USA
来源：
OBSTETRICS AND GYNECOLOGY | 2004年 / 103卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：102S / 102S
页数：1
相关论文
共 50 条
  • [41] Raloxifene reduces risk of new hyperlipidemia and reduces existing hyperlipidemia to target goals in postmenopausal women with osteoporosis
    Cox, DA
    Sarkar, S
    Harper, KD
    Barrett-Connor, E
    [J]. CIRCULATION, 2002, 106 (19) : 748 - 748
  • [42] Preventing postmenopausal osteoporosis: An update on raloxifene
    Kauffman, RF
    Bryant, HI
    Yang, N
    Harper, KD
    Huster, WJ
    Walls, EL
    Lufkin, EG
    [J]. DRUG NEWS & PERSPECTIVES, 1999, 12 (04) : 223 - 233
  • [43] Effects of raloxifene on fracture risk in postmenopausal women: The raloxifene use for the heart trial
    Ensrud, Kristine E.
    Stock, John L.
    Barrett-Connor, Elizabeth
    Grady, Deborah
    Mosca, Lori
    Khaw, Kay-Tee
    Zhao, Qingwen
    Agnusdei, Donato
    Cauley, Jane A.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (01) : 112 - 120
  • [44] Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
    Carolyn J. Crandall
    [J]. Current Osteoporosis Reports, 2015, 13 : 287 - 301
  • [45] OSTEOPOROSIS RISK ASSESSMENT TOOLS TO SCREEN POSTMENOPAUSAL WOMEN IN SRI LANKA
    Subasinghe, H.
    Lekamwasam, S.
    Ball, P.
    Morrissey, H.
    Waidyaratne, E. I.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S497 - S497
  • [46] CLINICAL PERFORMANCE OF OSTEOPOROSIS RISK ASSESSMENT TOOLS IN SERBIAN POSTMENOPAUSAL WOMEN
    Nikitovic, M.
    Snezana, P.
    Violeta, C.
    Vasic, J.
    Gojkovic, F.
    Trumbic, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 123 - 123
  • [47] Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
    Crandall, Carolyn J.
    [J]. CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (05) : 287 - 301
  • [48] OSTEOPOROSIS RISK FACTORS FOR POSTMENOPAUSAL WOMEN
    Cevei, Mariana I.
    Stoicanescu, Dorina C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S216 - S216
  • [49] Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women
    Lee, Wen-Ling
    Chao, Hsiang-Tai
    Cheng, Ming-Huei
    Wang, Peng-Hui
    [J]. MATURITAS, 2008, 60 (02) : 92 - 107
  • [50] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis.
    Adachi, JD
    Reginster, J
    Qu, Y
    Siddhanti, S
    Keech, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S379 - S379
12345